|
|
專題 |
最後回覆 |
暱稱 |
內容 |
中國泰凌醫藥集團有限公司 |
2020-01-30T09:08 |
財經茄呢啡 |
有內地傳媒報道,泰凌醫藥(1011)一款藥物氨溴索有治療武漢肺炎的潛力,泰凌昨日升幅逾52%,收報0.29元;如確認氨溴索能有效治療武漢肺炎,泰凌將大量生產。 |
中國泰凌醫藥集團有限公司 |
2013-04-07T08:34 |
財經茄呢啡 |
泰凌醫藥(1011)為內地最大藥品及疫苗推廣銷售服務商,但今次出現的甲型禽流感病毒基因或已改變,現存的針藥及疫苗未必有用,故近期股價升勢可能過急。 |
|
|
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window